droxidopa has been researched along with Dizzyness in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Biaggioni, I; Haumann, B; Kanodia, J; Kaufmann, H; Norcliffe-Kaufmann, L; Shibao, CA; Vickery, R; Wang, W | 1 |
Farrell, J; Kim, MJ | 1 |
Khemani, P; Sin, MK | 1 |
Arthur Hewitt, L; Biaggioni, I; Kaufmann, H; Rowse, GJ | 1 |
Gupta, F; Karabin, B; Mehdirad, A | 1 |
Biaggioni, I; Feirtag, M; Freeman, R; Hewitt, LA; Kaufmann, H; Low, P; Mathias, CJ; Mauney, J; Pedder, S | 1 |
Ohkido, I; Takane, K; Tanabe, N; Tanno, Y; Yamamoto, I; Yokoo, T; Yokoyama, K | 1 |
Birkmayer, G; Birkmayer, W; Lechner, H; Riederer, P | 1 |
Mino, M; Tanaka, H; Yamaguchi, H | 1 |
4 trial(s) available for droxidopa and Dizzyness
Article | Year |
---|---|
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial.
Topics: Aged; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Humans; Hypotension, Orthostatic; Male; Middle Aged; Norepinephrine | 2021 |
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Surveys and Questionnaires; Walking | 2017 |
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Topics: Aged; Autonomic Agents; Autonomic Nervous System Diseases; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Nervous System Diseases; Parkinson Disease; Posture; Pure Autonomic Failure; Time Factors; Treatment Outcome | 2014 |
The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance.
Topics: Adolescent; Antiparkinson Agents; Blood Pressure; Child; Dizziness; Droxidopa; Female; Heart Rate; Humans; Hypotension, Orthostatic; Male | 1996 |
5 other study(ies) available for droxidopa and Dizzyness
Article | Year |
---|---|
Orthostatic Hypotension: A Practical Approach.
Topics: Accidental Falls; Adolescent; Adult; Aged; Blood Pressure; Chest Pain; Diabetes Mellitus; Diet; Dizziness; Droxidopa; Fludrocortisone; Heart Disease Risk Factors; Heart Rate; Humans; Hypotension, Orthostatic; Middle Aged; Midodrine; Quality of Life; Supine Position; Systole; Young Adult | 2022 |
Neurogenic Orthostatic Hypotension: An Underrecognized Complication of Parkinson Disease.
Topics: Accidental Falls; Aged; Caregivers; Cognitive Dysfunction; Dizziness; Droxidopa; Humans; Hypotension, Orthostatic; Male; Neuroscience Nursing; Parkinson Disease; Patient Education as Topic; Quality of Life | 2020 |
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
Topics: Accidental Falls; Aged, 80 and over; Antiparkinson Agents; Blood Pressure Monitoring, Ambulatory; Dizziness; Droxidopa; Humans; Hypotension, Orthostatic; Male; Parkinson Disease; Patient Education as Topic; Supine Position | 2017 |
Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient.
Topics: Aged; Baroreflex; Carotid Sinus; Cold Temperature; Dialysis Solutions; Dizziness; Droxidopa; Enteral Nutrition; Gastrostomy; Humans; Hypertension; Hypotension; Kidney Failure, Chronic; Male; Midodrine; Posture; Radiation Injuries; Radiotherapy; Reflex, Abnormal; Renal Dialysis; Sodium; Sympathetic Nervous System; Temperature; Tongue Neoplasms | 2014 |
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Topics: Aged; Antiparkinson Agents; Benserazide; Blood Pressure; Dizziness; Droxidopa; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Long-Term Care; Male; Norepinephrine; Parkinson Disease; Serine | 1983 |